Tag: R&D

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation. Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

Ono Pharmaceutical and twoXAR in R&D Collaboration

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that the c...

Servier and Oncodesign Team Up for R&D Parkinson’s Drug

Servier, an international pharmaceutical company governed by a non-profit foundation, and biopharmaceutical company, Oncodesign have announced a strategic partnership for the research and development ...

WuXi STA and Ark Biosciences Team Up for CMC Development

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Ark Biosciences, a global biotech company focusing on innovative drug discovery and development, especially in the area of ...

Abpro and NJCTTQ in Immuno-Oncology Collaboration

Collaboration to result in multiple new immuno-oncology bispecific therapeutic programs leveraging Abpro’s proprietary DiversImmuneTM antibody discovery platform for T-cell engagement. Abpro, a bio...

Morphic and Janssen in R&D Partnership

Morphic Therapeutic (Morphic), a biotechnology company developing oral integrin therapies, announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janss...

Abilita Bio and Amgen in Multi-Target Research Team

amgen
Abilita Bio, Inc. announced that it has entered into a multi-target research collaboration agreement with Amgen, a world leader in biotechnology. Under the terms of the agreement, Abilita Bio will lev...

Merck Expands US R&D Facility

Merck KGaA, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, is investing $70 million to expand its R&D facility in Billerica, MA. The new 145,000 sq.-ft. buildi...

SP Scientific Announced First New Advanced Freeze Dryers

The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation. SP Scientific has announced the...

Merck Expands R&D Facility

German drugs and Chemical group Merck KGaA announced a $70 million investment to expand its state of the art research and development (R&D) facility in Billerica, Massachusetts. The new buildin...

Cannassure and Cannika Team Up for Medical Cannabis Innovation

Cannassure Therapeutics announces its collaboration with Cannika Holdings, an agritech incubator specializing in cannabis innovation. Cannika will operate out of the Cannassure campus, utilizing their...

UK Has Lack of Students Studying STEM Subjects

Highly skilled scientific roles could move elsewhere if the situation is not addressed as a matter of urgency. The Association of the British pharmaceutical industry, ABPI, has released "Bridging t...

Orion Oyj Loaned €100m for R&D New Medicines

Finnish pharmaceutical firm Orion Oyj has signed a loan agreement of €100m with the European Investment Bank in Espoo. The financing is designed to support Orion’s investments into research and dev...

CRISPR and ProBioGen to Develop Novel Technologies

CRISPR Therapeutics, a biopharmaceutical company focused on creating gene-based medicines for serious diseases, and ProBioGen, a German service and technology provider, have entered a multi-year resea...

Shake-up in AstraZeneca

British pharma giant has aligned therapy R&D units to new commercial strategy and hired oncology expert Jose Baselga to lead new phase in development. AstraZeneca has announced a major shake-up...

Lupin Plans to Develop First-to-Market Products

Drug maker Lupin is in the process of developing a pipeline of products under its new drug discovery programme to treat various diseases like cancer and metabolic disorders, a top company official sai...

Graphene Can Detect Neurodegenerative Diseases

Researchers have discovered that the sensitive nature of graphene—one of the world’s strongest materials—makes it a good candidate to detect and diagnose diseases. A team of researchers from the Un...